SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Transworld Home HealthCare, Inc
- - - --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- - - --------------------------------------------------------------------------------
(Title of Class of Securities)
894081-10-8
- - - --------------------------------------------------------------------------------
(CUSIP Number)
Joseph J. Raymond
Transworld Home HealthCare, Inc.
11 Skyline Drive, Hawthorne, New York 10532
- - - --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
April 24, 1996
- - - --------------------------------------------------------------------------------
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement of Schedule 13G to report
the acquisition which is the subject of the Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Check the following box if a fee is being paid with this statement [ ].
(A fee is not required only if the reporting person: (1) has a previous
statement on file reporting beneficial ownership of more than five percent of
the class of securities described in Item 1; and (2) has filed no amendment
subsequent thereto reporting beneficial ownership of five percent or less of
such class.) (See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filed out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
<PAGE>
Schedule 13D
- - - ---------------------- ----------------------
CUSIP NO. 894081-10-8 Page 2 of 5 Pages
- - - ---------------------- ----------------------
- - - --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Joseph J. Raymond
- - - --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
- - - --------------------------------------------------------------------------------
3 SEC USE ONLY
- - - --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
N/A
- - - --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(a) [ ]
- - - --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
- - - --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 677,133
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH 37,764
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 677,133
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
37,764
- - - --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
677,133
- - - --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[X]
- - - --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
12.4%
- - - --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- - - --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
- - - ---------------------- ----------------------
CUSIP NO. 894081-10-8 Page 3 of 5 Pages
- - - ---------------------- ----------------------
Item 1. Security and Issuer
This statement relates to the common stock, par value $0.01
per share (the "Shares"), of Transworld Home HealthCare, Inc. (the "Company").
The address of the principal executive offices of the Company is 11 Skyline
Drive, Hawthorne, New York 10532.
Item 2. Identity and Background
This statement is filed by Joseph J. Raymond. Mr. Raymond's business
address is c/o Transworld Home HealthCare, Inc., 11 Skyline Drive, Hawthorne,
New York 10532.
Mr. Raymond is presently employed as Chairman of the Board and Chief
Executive Officer of the Company. The address of the Company is as herein
stated.
Mr. Raymond has not, during the last five years, been convicted in any
criminal proceeding (excluding traffic violations or similar misdemeanors) or
been a party to any civil proceeding of any judicial or administrative body.
Mr. Raymond is a citizen of the United States of America.
Item 3. Source and Amount of Funds or Other Consideration
Not applicable.
Item 4. Purposes of Transaction
On April 24, 1996, Mr. Raymond gifted 60,000 Shares. Mr. Raymond does not
have any plans or proposals which relate to or would result in any of the
actions specified in clauses (a) through (j) of this Item 4.
<PAGE>
SCHEDULE 13D
- - - ---------------------- ----------------------
CUSIP NO. 894081-10-8 Page 4 of 5 Pages
- - - ---------------------- ----------------------
Item 5. Interest in Securities of the Issuer
(a) Mr. Raymond beneficially owns 677,133 Shares, which constitutes
12.4% of the outstanding Shares of the Company.
(b) Mr. Raymond has sole power to vote or direct the vote, and sole
power to dispose or direct the disposition of 677,133 Shares. Mr. Raymond
is a co-trustee of four irrevocable family trusts which in the aggregate
hold 37,764 Shares. Mr. Raymond disclaims beneficial ownership of the
Shares held by each of the foregoing trusts.
(c) There have been no transactions with respect to Shares, other than
as described in Item 4, effected by Mr. Raymond during the past sixty (60)
days.
(d) No persons other than Mr. Raymond have the right to receive or the
power to direct the receipt of dividends from or proceeds from the sale of,
the Shares beneficially owned by Mr. Raymond.
(e) Not applicable.
Item 6. Contracts; Arrangements, Understandings or Relationships
With Respect to Securities of the Issuer.
Not applicable.
Item 7. Materials to be Filed as Exhibits
Not applicable.
<PAGE>
SCHEDULE 13D
- - - ---------------------- ----------------------
CUSIP NO. 894081-10-8 Page 5 of 5 Pages
- - - ---------------------- ----------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: May 7, 1996
/s/JOSEPH J. RAYMOND
------------------
Joseph J. Raymond
